Chapter title |
Design and Selection of Antisense Oligonucleotides Targeting Transforming Growth Factor Beta (TGF-β) Isoform mRNAs for the Treatment of Solid Tumors.
|
---|---|
Chapter number | 9 |
Book title |
Gene Therapy of Solid Cancers
|
Published in |
Methods in molecular biology, January 2015
|
DOI | 10.1007/978-1-4939-2727-2_9 |
Pubmed ID | |
Book ISBNs |
978-1-4939-2726-5, 978-1-4939-2727-2
|
Authors |
Jaschinski, Frank, Korhonen, Hanna, Janicot, Michel, Frank Jaschinski, Hanna Korhonen, Michel Janicot |
Abstract |
Transforming growth factor beta isoforms (TGF-β1, -β2, and -β3) are cytokines associated with a wide range of biological processes in oncology including tumor cell invasion and migration, angiogenesis, immunosuppression, as well as regulation of tumor stem cell properties. Hence, blocking the TGF-β signaling pathways may have a multifold therapeutic benefit for the treatment of solid tumors. Here, we describe the identification and selection processes for the development of highly potent and selective chemically modified antisense oligodeoxynucleotides (fully phosphorothioate locked nucleic acid gapmers) allowing effective and selective suppression of TGF-β isoform expression in cell-based assays and in vivo preclinical models. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 12 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 3 | 25% |
Student > Postgraduate | 2 | 17% |
Other | 1 | 8% |
Student > Bachelor | 1 | 8% |
Lecturer > Senior Lecturer | 1 | 8% |
Other | 0 | 0% |
Unknown | 4 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 3 | 25% |
Biochemistry, Genetics and Molecular Biology | 2 | 17% |
Medicine and Dentistry | 2 | 17% |
Immunology and Microbiology | 1 | 8% |
Unknown | 4 | 33% |